
Mergers & Acquisitions
Private Equity
Public Company Representation
Healthcare & Life Sciences
Technology
Robbie McLaren is a Partner at Latham & Watkins, based in London. As the Global Vice Chair of the firm’s Healthcare & Life Sciences Industry Group, he advises healthcare, technology, and life sciences companies throughout their corporate life cycle. Robbie has extensive experience in cross-border mergers and acquisitions, private equity, joint ventures, and public company representation. He has been instrumental in significant transactions for market innovators, leveraging his expertise to drive successful outcomes. Previously, he served as Co-Chair of the London Corporate Department, further solidifying his leadership within the firm.
Healthcare and Life Sciences Transactions
Investment Funds and Private Equity
Technology and Aerospace
- Immedica Pharma acquired Immedica Pharma from Immedica Pharma in a private equity on 2024-04-23. - Deal value was 11000000000 (source: AI Estimation) Ownership: equal ownership (post-closing partnership); Sector: Pharmaceuticals; Location: Europe. - Acquirer-side legal counsel was not specified.
Apr 23 2024
11B
Private Equity
Partner
2016 – Unknown
Associate
2007 – 2016
Assistant
2004 – 2007
- Canva acquired the target/assets from Serif Group Limited in a acquisition on 2024-03-27. - Deal value was 3800000000 (source: AI Estimation) Sector: Technology; Location: UK. - On the acquirer side, Latham & Watkins advised, led by Robbie McLaren, Medha Marathe, Emil George, Beatrice Leung, Michael Podolny.
Mar 27 2024
4B
M&A
Apr 20
1 min
Diploma in Legal Practice, University of Edinburgh
2004
LLB (Hons), University of Edinburgh
2003